<?xml version="1.0" encoding="UTF-8"?><TED_EXPORT xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="ted/R2.0.8.S03/publication" xmlns:n2016="ted/2016/nuts" xsi:schemaLocation="ted/R2.0.8.S03/publication TED_EXPORT.xsd" DOC_ID="180163-2018" EDITION="2018080"><TECHNICAL_SECTION><RECEPTION_ID>18-182119-001</RECEPTION_ID><DELETION_DATE>20180801</DELETION_DATE><FORM_LG_LIST>ES </FORM_LG_LIST><COMMENTS>From Convertor</COMMENTS></TECHNICAL_SECTION><LINKS_SECTION><XML_SCHEMA_DEFINITION_LINK xlink:type="simple" xlink:href="http://ted.europa.eu" xlink:title="TED WEBSITE"/><OFFICIAL_FORMS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><FORMS_LABELS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/><ORIGINAL_CPV_LINK xlink:type="simple " xlink:href="http://ted.europa.eu"/><ORIGINAL_NUTS_LINK xlink:type="simple" xlink:href="http://ted.europa.eu"/></LINKS_SECTION><CODED_DATA_SECTION><REF_OJS><COLL_OJ>S</COLL_OJ><NO_OJ>80</NO_OJ><DATE_PUB>20180425</DATE_PUB></REF_OJS><NOTICE_DATA><NO_DOC_OJS>2018/S 080-180163</NO_DOC_OJS><URI_LIST><URI_DOC LG="ES">http://ted.europa.eu/udl?uri=TED:NOTICE:180163-2018:TEXT:ES:HTML</URI_DOC></URI_LIST><LG_ORIG>ES</LG_ORIG><ISO_COUNTRY VALUE="ES"/><IA_URL_GENERAL>www.madrid.org</IA_URL_GENERAL><ORIGINAL_CPV CODE="33650000">General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</ORIGINAL_CPV><VALUES_LIST><VALUES TYPE="GLOBAL"><SINGLE_VALUE><VALUE CURRENCY="EUR">535 612,29</VALUE></SINGLE_VALUE></VALUES><VALUES TYPE="CONTRACT"><SINGLE_VALUE><VALUE CURRENCY="EUR">535 612,29</VALUE></SINGLE_VALUE></VALUES></VALUES_LIST></NOTICE_DATA><CODIF_DATA><DS_DATE_DISPATCH>20180423</DS_DATE_DISPATCH><AA_AUTHORITY_TYPE CODE="6">Body governed by public law</AA_AUTHORITY_TYPE><TD_DOCUMENT_TYPE CODE="7">Contract award notice</TD_DOCUMENT_TYPE><NC_CONTRACT_NATURE CODE="2">Supplies</NC_CONTRACT_NATURE><PR_PROC CODE="T">Negotiated without a prior call for competition</PR_PROC><RP_REGULATION CODE="4">European Union</RP_REGULATION><TY_TYPE_BID CODE="9">Not applicable</TY_TYPE_BID><AC_AWARD_CRIT CODE="Z">Not specified</AC_AWARD_CRIT><MA_MAIN_ACTIVITIES CODE="H">Health</MA_MAIN_ACTIVITIES><HEADING>01203</HEADING><DIRECTIVE VALUE="2004/18/EC"/></CODIF_DATA></CODED_DATA_SECTION><TRANSLATION_SECTION><ML_TITLES><ML_TI_DOC LG="BG"><TI_CY>Иcпaния</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Общи противовъзпалителни средства за системна употреба, ваксини, антинеопласти и имуномодулатори</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="CS"><TI_CY>Španělsko</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Antiinfektiva pro systémové užití, očkovací látky, antineoplastika a imunomodulátory</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DA"><TI_CY>Spanien</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Antiinfektive midler til systemisk brug, vacciner, cytostatike/cytotoxiske midler samt immunmodulerende midler</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="DE"><TI_CY>Spanien</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Antiinfektiva zur systemischen Anwendung, Impfstoffe, Antineoplastika und Immunmodulatoren</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EL"><TI_CY>Ισπανία</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Φάρμακα κατά των λοιμώξεων συστηματικής χρήσης, εμβόλια, αντινεοπλασματικά και ανοσορρυθμιστικά φάρμακα</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="EN"><TI_CY>Spain</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ES"><TI_CY>España</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Antiinfecciosos generales para uso sistémico, vacunas, antineoplásicos e inmunomoduladores</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="ET"><TI_CY>Hispaania</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Üldised infektsioonivastased ained süsteemseks kasutamiseks, vaktsiinid, antineoplastilised ja immuunmoduleerivad ained</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FI"><TI_CY>Espanja</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Systeemisesti vaikuttavat infektiolääkkeet, rokotteet sekä syöpälääkkeet ja immunomodulantit</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="FR"><TI_CY>Espagne</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Anti-infectieux généraux à usage systémique, vaccins, antinéoplasiques et immunomodulateurs</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="GA"><TI_CY>Spáinn, an</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HR"><TI_CY>Španjolska</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Opća protuupalna sredstva za sustavno liječenje, cjepiva, antineoplastična sredstva i imunomodulatori</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="HU"><TI_CY>Spanyolország</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Általános fertőzésellenes szerek szisztémás használatra, vakcinák, daganatellenes és immunmodulátor szerek</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="IT"><TI_CY>Spagna</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Antinfettivi generali per uso sistemico, vaccini, agenti antineoplastici e immunomodulatori</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LT"><TI_CY>Ispanija</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Sistemiškai veikiantys priešinfekciniai vaistai, vakcinos, antinavikiniai vaistai ir imunomoduliatoriai</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="LV"><TI_CY>Spānija</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Vispārēji pretinfekcijas līdzekļi sistēmiskai lietošanai, vakcīnas, antineoplastiskie līdzekļi un imūnmodulatori</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="MT"><TI_CY>Spanja</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Anti-infettivi ġenerali għall-użu sistematiku, vaċċini, antineoplastika u aġenti immunomodulaturi</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="NL"><TI_CY>Spanje</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Algemene infectiewerende middelen voor systemisch gebruik, vaccins, antineoplastica en immunomodulerende middelen</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PL"><TI_CY>Hiszpania</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Ogólne środki przeciwinfekcyjne do użytku ogólnoustrojowego, szczepionki, środki przeciwnowotworowe oraz immunomodulacyjne</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="PT"><TI_CY>Espanha</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Anti-infecciosos gerais de uso sistémico, vacinas, antineoplásicos e imunomoduladores</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="RO"><TI_CY>Spania</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Antiinfecţioase generale pentru uz sistemic, vaccinuri, antineoplazice şi imunomodulatoare</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SK"><TI_CY>Španielsko</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Všeobecné antiinfekčné látky na systémové použitie, očkovacie látky, antineoplastické prostriedky a imunomodulačné činidlá</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SL"><TI_CY>Španija</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Antimikotiki za sistemsko zdravljenje, cepiva, zdravila z delovanjem na novotvorbe in imunomodulatorji</TI_TEXT></ML_TI_DOC><ML_TI_DOC LG="SV"><TI_CY>Spanien</TI_CY><TI_TOWN>Fuenlabrada</TI_TOWN><TI_TEXT>Antiinfektiva medel för systemiskt bruk, vacciner, cytostatika/cytotoxiska medel, samt immunmodulerande medel</TI_TEXT></ML_TI_DOC></ML_TITLES><ML_AA_NAMES><AA_NAME LG="ES">Ente Público Hospital Universitario de Fuenlabrada</AA_NAME></ML_AA_NAMES></TRANSLATION_SECTION><FORM_SECTION><CONTRACT_AWARD CATEGORY="ORIGINAL" FORM="3" LG="ES" VERSION="R2.0.8.S03.E01"><FD_CONTRACT_AWARD CTYPE="SUPPLIES"><CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><CA_CE_CONCESSIONAIRE_PROFILE><ORGANISATION><OFFICIALNAME>Ente Público Hospital Universitario de Fuenlabrada</OFFICIALNAME></ORGANISATION><ADDRESS>C/ Camino del Molino, 2</ADDRESS><TOWN>Fuenlabrada (Madrid)</TOWN><POSTAL_CODE>28942</POSTAL_CODE><COUNTRY VALUE="ES"/><PHONE>+34 916006142</PHONE><E_MAILS><E_MAIL>suministros.hflr@salud.madrid.org</E_MAIL></E_MAILS><FAX>+34 916006712</FAX></CA_CE_CONCESSIONAIRE_PROFILE><INTERNET_ADDRESSES_CONTRACT_AWARD><URL_GENERAL>www.madrid.org</URL_GENERAL></INTERNET_ADDRESSES_CONTRACT_AWARD></NAME_ADDRESSES_CONTACT_CONTRACT_AWARD><TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF><TYPE_AND_ACTIVITIES><TYPE_OF_CONTRACTING_AUTHORITY VALUE="BODY_PUBLIC"/><TYPE_OF_ACTIVITY VALUE="HEALTH"/></TYPE_AND_ACTIVITIES></TYPE_AND_ACTIVITIES_AND_PURCHASING_ON_BEHALF></CONTRACTING_AUTHORITY_INFORMATION_CONTRACT_AWARD><OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><DESCRIPTION_AWARD_NOTICE_INFORMATION><TITLE_CONTRACT><P>PNSP SUM 18/06 medicamentos exclusivos ViiV</P></TITLE_CONTRACT><TYPE_CONTRACT_LOCATION_W_PUB><TYPE_CONTRACT VALUE="SUPPLIES"/></TYPE_CONTRACT_LOCATION_W_PUB><SHORT_CONTRACT_DESCRIPTION><P>Suministro de medicamentos exclusivos ViiV.</P></SHORT_CONTRACT_DESCRIPTION><CPV><CPV_MAIN><CPV_CODE CODE="33650000"/></CPV_MAIN></CPV></DESCRIPTION_AWARD_NOTICE_INFORMATION><TOTAL_FINAL_VALUE><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="535612.29">535 612,29</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></TOTAL_FINAL_VALUE></OBJECT_CONTRACT_INFORMATION_CONTRACT_AWARD_NOTICE><PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><TYPE_OF_PROCEDURE_DEF><F03_PT_NEGOTIATED_WITHOUT_COMPETITION><ANNEX_D><NO_MANUFACTURED_BY_DIRECTIVE/><JUSTIFICATION_CHOICE_NEGOCIATED_PROCEDURE><REASONS_PROVIDED_PARTICULAR_TENDERER><REASONS_PROVIDED_PARTICULAR_TENDERER_EXCLUSIVE_RIGHTS/></REASONS_PROVIDED_PARTICULAR_TENDERER><NO_EXTREME_URGENCY_EVENTS_UNFORESEEABLE/><NO_ADDITIONAL_WORKS/><NO_SUPPLIES_QUOTED_PURCHASED_COMMODITY_MARKET/></JUSTIFICATION_CHOICE_NEGOCIATED_PROCEDURE><NO_ONLY_IRREGULAR_INACCEPTABLE_TENDERERS/><REASON_CONTRACT_LAWFUL/></ANNEX_D></F03_PT_NEGOTIATED_WITHOUT_COMPETITION></TYPE_OF_PROCEDURE_DEF><ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD><FILE_REFERENCE_NUMBER><P>PNSP SUM 2018/06</P></FILE_REFERENCE_NUMBER></ADMINISTRATIVE_INFORMATION_CONTRACT_AWARD></PROCEDURE_DEFINITION_CONTRACT_AWARD_NOTICE><AWARD_OF_CONTRACT><CONTRACT_AWARD_DATE><DAY>14</DAY><MONTH>03</MONTH><YEAR>2018</YEAR></CONTRACT_AWARD_DATE><ECONOMIC_OPERATOR_NAME_ADDRESS><CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME><ORGANISATION><OFFICIALNAME>Laboratorios ViiV Healthcare, S. L.</OFFICIALNAME></ORGANISATION></CONTACT_DATA_WITHOUT_RESPONSIBLE_NAME></ECONOMIC_OPERATOR_NAME_ADDRESS><CONTRACT_VALUE_INFORMATION><COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE CURRENCY="EUR"><VALUE_COST FMTVAL="535612.29">535 612,29</VALUE_COST><EXCLUDING_VAT/></COSTS_RANGE_AND_CURRENCY_WITH_VAT_RATE></CONTRACT_VALUE_INFORMATION></AWARD_OF_CONTRACT><COMPLEMENTARY_INFORMATION_CONTRACT_AWARD><NOTICE_DISPATCH_DATE><DAY>23</DAY><MONTH>04</MONTH><YEAR>2018</YEAR></NOTICE_DISPATCH_DATE></COMPLEMENTARY_INFORMATION_CONTRACT_AWARD></FD_CONTRACT_AWARD></CONTRACT_AWARD></FORM_SECTION></TED_EXPORT>